Form D · Biotechnology
ENTRIGUE SURGICAL INC
San Antonio, TX · CIK 0001446076
Offering snapshot reported Nov 21, 2011 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $4.67K Reported outside-investor minimum
- First sale
- Oct 26, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2011 | Initial | $4,000,000 | No comparison | 18 | SEC filing |
| May 5, 2010 | Initial | $10,878,234 | No comparison | 14 | SEC filing |
| Nov 25, 2009 | Initial | $3,171,773 | No comparison | 8 | SEC filing |
| Sep 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169025
Source: Form D, filed Nov 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fred B. Dinger Iii | Director, Executive |
| Richard B. Emmitt | Director |
| Donald A. Gonzales | Director |
| Anthony J. Natale | Director |
| Gabriele G. Niederauer | Executive |
| Joseph D. Oliver Iii | Executive |
| John T. Treace | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12672 Silicon Drive Suite 150
San Antonio, TX, 78249
San Antonio, TX, 78249